Reviewing the Role of VEGF-Targeting Agents in the Treatment of GI Cancers

In this educational activity an expert panel comprising Jordi Bruix MD Yelena Y. Janjigian MD John L. Marshall MD and Neeta Somaiah MD discuss the most recent clinical data informing the optimal use of VEGF-targeted therapies in the care of patients with advanced CRC HCC gastric/GEJ cancer and GIST.

Share

Program Content

Activities

Downlodable Slideset
Reviewing the Role of VEGF-Targeting Agents in the Treatment of GI Cancers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 13, 2017

Expires: March 12, 2018

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Bayer Healthcare Pharma